Skip to main content
. 2020 Jul 14;72(4):799–813. doi: 10.1007/s43440-020-00131-0

Fig. 5.

Fig. 5

EGFR-TK receptor binding sites. ATP binding sites on EGFR, diagram c represents the superimposition of a and b. Diagram c demonstrates how the allosteric site is associated with the ATP site when the drug/inhibitor/ligand targets the EGFR. The allosteric site has the potential to stabilize the whole kinase domain by binding along with ATP [read the text for details and ref. (44, 45)]